SCHEMBL2721647

SCHEMBL2721647

COc1ccc(-c2onc(-c3ccccc3Cl)c2-c2cccc(F)c2C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.45
PTGS1 P23219 1/20 0.45
MAPT P10636 3/20 0.45
TP53 P04637 2/20 0.45
NPC1 O15118 1/20 0.45
NFKB1 P19838 1/20 0.45
RAB9A P51151 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GPBAR1 Q8TDU6 3/20 0.44
LMNA P02545 3/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 3/20 0.40
HSP90AA1 P07900 1/20 0.40
NPSR1 Q6W5P4 3/20 0.40
TSHR P16473 1/20 0.39
SMURF1 Q9HCE7 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2730709 0.87 PTGS1 (0.47) PTGS2PTGS1MAPTTP53GPBAR1
SCHEMBL4549984 0.85 PTGS2 (0.50) PTGS2PTGS1MAPTNPC1RAB9A
SCHEMBL2723947 0.83 PTGS2 (0.59) PTGS2PTGS1MAPTNPC1RAB9A
SCHEMBL2723070 0.82 TP53 (0.47) PTGS2PTGS1MAPTTP53NPC1
SCHEMBL9956787 0.80 HSP90AA1 (0.51) PTGS2PTGS1NPC1RAB9AGPBAR1
SCHEMBL2721092 0.78 LMNA (0.42) PTGS2PTGS1MAPTTP53NPC1
SCHEMBL2730299 0.77 PTGS1 (0.51) PTGS2PTGS1MAPTNPC1NFKB1
SCHEMBL2721067 0.77 GPBAR1 (0.47) PTGS2PTGS1MAPTTP53NPC1
SCHEMBL2732046 0.75 PTGS1 (0.43) PTGS2PTGS1MAPTNPC1RAB9A
SCHEMBL2720986 0.75 PTGS1 (0.52) PTGS2PTGS1MAPTTP53NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012052395-A1 ISOXAZOLE DERIVATIVES USED AS OESTROGEN MODULATORS N. V. ORGANON (NL) 2012-04-26 WO disclosed